FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 83 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $634,836 | +34.1% | 142,981 | -0.3% | 0.00% | – |
Q2 2023 | $473,309 | -63.3% | 143,427 | -68.3% | 0.00% | – |
Q1 2023 | $1,288,063 | -54.7% | 451,952 | +15.7% | 0.00% | -100.0% |
Q4 2022 | $2,842,665 | +12.9% | 390,476 | +25.4% | 0.00% | 0.0% |
Q3 2022 | $2,518,000 | +66.8% | 311,293 | +1.0% | 0.00% | – |
Q2 2022 | $1,510,000 | -75.1% | 308,294 | +20.0% | 0.00% | -100.0% |
Q1 2022 | $6,076,000 | +30.6% | 256,926 | -2.3% | 0.00% | 0.0% |
Q4 2021 | $4,654,000 | -36.0% | 263,073 | +2.0% | 0.00% | 0.0% |
Q3 2021 | $7,275,000 | +218.8% | 257,872 | +18.4% | 0.00% | – |
Q2 2021 | $2,282,000 | -1.8% | 217,711 | +10.4% | 0.00% | – |
Q1 2021 | $2,323,000 | +4.4% | 197,208 | +3.8% | 0.00% | – |
Q4 2020 | $2,225,000 | +57.5% | 190,009 | +6.6% | 0.00% | – |
Q3 2020 | $1,413,000 | -53.9% | 178,169 | +6.4% | 0.00% | -100.0% |
Q2 2020 | $3,063,000 | +91.1% | 167,473 | +24.7% | 0.00% | – |
Q1 2020 | $1,603,000 | +88.8% | 134,285 | +163.0% | 0.00% | – |
Q4 2019 | $849,000 | +140.5% | 51,052 | -4.1% | 0.00% | – |
Q3 2019 | $353,000 | – | 53,211 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |